ArticleJournal of thoracic disease2020

Combination of apatinib and docetaxel in treating advanced non-squamous non-small cell lung cancer patients with wild-type EGFR: a multi-center, phase II trial.

Yong Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.